Effect of early blood counts on overall survival (OS) following glasdegib + LDAC in newly diagnosed AML: BRIGHT AML 1003 post hoc analysis.

Eunice S. Wang,Michael Heuser,Mikkael A. Sekeres,Cristina Papayannidis,Anna Candoni,Akil Merchant,Andrew Brown,Ashleigh OConnell,Wendy Ma,Geoffrey Chan,Jorge E. Cortes

Effect of early blood counts on overall survival (OS) following glasdegib + LDAC in newly diagnosed AML: BRIGHT AML 1003 post hoc analysis.

2020

Eunice S. Wang
Michael Heuser
Mikkael A. Sekeres
Cristina Papayannidis
Anna Candoni
Akil Merchant
Andrew Brown
Ashleigh OConnell
Wendy Ma
Geoffrey Chan
Jorge E. Cortes

7525Background: Addition of glasdegib (GLAS) to LDAC approximately doubled OS without significant worsening of myelosuppression-related complications, ostensibly by targeting leukemic stem cells de...

Keywords:

Post-hoc analysis
newly diagnosed
overall survival
Internal medicine
Medicine
Pathology
blood count

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations